All of New World Laboratories’ (NWL) therapeutics are designed to be either Regenerative or Personalized; most are both.
REGENERATIVE MEDICINE
Therapeutics that “replace or regenerate human cells, tissues or organs to restore or establish normal function.”
Therapeutics that Regenerate damaged cells, tissues or organs:
NWL-NSC (directly)
NWL-CSC (directly)
NWL-HSC (directly)
NWL-PSC (directly)
NWL-283 (indirectly)
NWL-117 (indirectly)
Regeneration Matrix™ (directly)
Therapeutics that Replace damaged cells, tissues or organs:
NWL-NSC (directly)
NWL-CSC (directly)
NWL-HSC (directly)
NWL-PSC (directly)
NWL-283 (indirectly)
Regeneration Matrix™ (indirectly)
Therapeutics that stimulate the body’s own repair mechanisms to heal previously irreparable cells, tissues or organs:
NWL-NSC (directly)
NWL-CSC (directly)
NWL-HSC (directly)
NWL-PSC (directly)
NWL-283 (indirectly)
NWL-117 (indirectly)
Regeneration Matrix™ (directly)
Although more costly than traditional drugs or therapeutics, Regenerative therapeutics have “curative-like” effects instead of just treating or masking symptoms.
PERSONALIZED MEDICINE
Therapeutics that are “tailored to the individual patient.”
Therapeutics designed according to the patient’s genetic makeup:
NWL-NSC (directly)
NWL-CSC (directly)
NWL-HSC (directly)
NWL-PSC (directly)
Other stem cells under development (directly)
Regeneration Matrix™ (if autologous)
Therapeutics designed according to the patient’s particular disease phenotype:
NWL-NSC (directly) (with genetic correction)
NWL-CSC (directly) (with genetic correction)
NWL-HSC (directly) (with genetic correction)
NWL-PSC (directly) (with genetic correction)
NWL-283 and other cell degeneration inhibitors (indirectly)
Although more costly than traditional drugs or therapeutics, Personalized therapeutics have significantly higher efficacy.
NWL creates therapeutics that have a greater efficacy/cost ratio than current treatments and standards of care, thus reducing overall healthcare costs while significantly increasing patients’ quality of life. In most of NWL’s product lines this is achieved by the therapeutic being simultaneously both a Regenerative Medicine & Personalized Medicine.
New autologous neural stem cells with the potential to realize the treatment promise of stem cell therapy in CNS indications....
A biomaterial for regenerating multiple tissues in accordance with the original organization and layering of the t...
COLLABORATORS
